Related Experiment Video
Updated: Mar 17, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
Published on: October 14, 2016
Primary Orbital Histiocytic Sarcoma in a Child Successfully Treated With Multiagent Chemotherapy
Nupur Mittal1, Vinay Aakalu, Sangeeta Mehendele
1Departments of *Pediatrics, Division of Pediatric Hematology Oncology §Ophthalmology and Visual Sciences ∥Pathology ¶Radiology, University of Illinois at Chicago †Department of Pediatrics, Division of Pediatric Hematology Oncology, Rush University Medical Center ‡Department of Pediatrics, Division of Pediatric Hematology Oncology, John. H. Stroger hospital, Chicago, IL.
Abstract:
Histiocytic sarcoma (HS), a malignant proliferation of mature tissue histiocytes presenting with single or multifocal extranodal tumors, is rarely seen in children. Primary orbital HS has never been reported in a child. Disseminated disease to the bone marrow typically has an aggressive course and poor prognosis. There is no consensus currently on the optimal therapeutic approach for HS. We present the case of a 2-year-old girl with orbital HS with likely bone marrow involvement treated successfully with multiagent chemotherapy, now in complete remission and disease free 3.5 years from end of therapy.
